Newsroom

When developing clinical strategy, applying familiar business principles to the specific requirements of clinical..

Recently, Cytel co-founder Professor Cyrus Mehta noted that, “Clinical trial design selection is too much like an art,..

For much of the past three decades, even as methodologies for clinical trial design have advanced and refined, the idea..

WALTHAM, MASS -  After months of successfully deploying its new strategic decision-support software Solara, Cytel Inc.,..

The use of wearable and digital technology requires considerations for both drugs and devices regulations, and..

Over the past ten years High-Performance Computing (HPC) has transformed medical research through advances in genomics,..

With wearables likely to become a regular part of clinical trial design, statisticians could benefit by familiarizing..

In the recent years, Oncology trials are seeing a technological shift that is expected to make them faster and more..

The convergence of several distinct trends has made wearables an increasingly attractive option for use in confirmatory..